共 18 条
[1]
Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Ashcroft DM,Wan Po AL,Williams HC,et al. Br J Dermatol . 1999
[2]
Measurement of involved surface area in patients with psoriasis. Ramsay B,Lawrence CM. Br J Dermatol . 1991
[3]
Assessment of severity score in patients with psoriasis. Vardy DA,Guberman D,Lichtenstein DA,et al. Br J Dermatol . 1993
[4]
The Psoriasis Area and Severity Index and alternative approaches for the assessment of severity: persisting areas of confusion. van de Kerkhof PC. Br J Dermatol . 1997
[5]
The outcomes movement and new measures of the severity of psoriasis. Mckenna KE,Stern RS. Journal of the American Academy of Dermatology . 1996
[6]
Psoriasis: comparison of immunological markers in patients with acute and remission phase. De Pita O,Ruffelli M,Cadoni S,et al. Journal of Dermatological Science . 1996
[7]
Clinical evaluation of a more rapid and sensitive Psoriasis Assessment Severity Score (PASS), and its comparison with the classic method of Psoriasis Area and Severity Index(PASI), before and after climatotherapy at the Dead-Sea. Harari M,Shani J,Hristakieva E,et al. International Journal of Dermatology . 2000
[8]
Quality of life measures in psoriasis: a critical appraisal of their quality. Ashcroft DM,Li Wan Po A,Williams HC,et al. Journal of Clinical Pharmacy and Therapeutics . 1998
[9]
Dermatology quality of life scales--a measure of the impact of skin diseases. Morgan M,McCreedy R,Simpson J,et al. Br J Dermatol . 1997
[10]
Plasma polymorphonuclear leukocyte elastase levels and its relation to disease activity in psoriasis. Orem A,Deger O,Cimsit G,et al. Clinica Chimica Acta . 1997